Search

Your search keyword '"Azulay, Jean Philippe"' showing total 321 results

Search Constraints

Start Over You searched for: Author "Azulay, Jean Philippe" Remove constraint Author: "Azulay, Jean Philippe" Language english Remove constraint Language: english
321 results on '"Azulay, Jean Philippe"'

Search Results

2. Imbalanced motivated behaviors according to motor sign asymmetry in drug-naïve Parkinson’s disease

3. Immediate-release/extended-release amantadine (OS320) to treat Parkinson's disease with levodopa-induced dyskinesia: Analysis of the randomized, controlled ALLAY-LID studies

4. Electrophysiological features of the peripheral neuropathy in patients with pathologic biallelic RFC1 repeat expansions.

7. Increasing involvement of CAPN1 variants in spastic ataxias and phenotype-genotype correlations

8. Magnetic Resonance Imaging Measures to Track Atrophy Progression in Progressive Supranuclear Palsy in Clinical Trials.

9. Molecular Imaging in CANVAS: A Contribution for Differential Diagnosis?

14. Naftazone in advanced Parkinson's disease: An acute L-DOPA challenge randomized controlled trial

15. Severity dependent distribution of impairments in PSP and CBS: Interactive visualizations

18. Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson's disease with early motor complications (EARLYSTIM trial): secondary analysis of an open-label randomised trial

20. Motivational and cognitive predictors of apathy after subthalamic nucleus stimulation in Parkinson's disease.

21. A Case Report of SYNE1 Deficiency-Mimicking Mitochondrial Disease and the Value of Pangenomic Investigations.

22. Author Correction: Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial

26. Relevance of corpus callosum splenium versus middle cerebellar peduncle hyperintensity for FXTAS diagnosis in clinical practice

27. Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial

28. Trial of Prasinezumab in Early-Stage Parkinson's Disease

32. Delayed-Onset Friedreichʼs Ataxia Revisited

35. Clinical and genetic characteristics of late-onset Huntington's disease

37. Polymorphism of the dopamine transporter type 1 gene modifies the treatment response in Parkinson’s disease

38. Early Parkinson's Disease Phenotypes Tailored by Personality, Behavior, and Motor Symptoms.

39. Fatigue in de novo Parkinson's Disease: Expanding the Neuropsychiatric Triad?

42. Rivastigmine in apathetic but dementia and depression-free patients with Parkinsonʼs disease: a double-blind, placebo-controlled, randomised clinical trial

43. Reducing Attentional Bias in Individuals With Alcohol Use Disorders With a Tablet Application: A Randomized Controlled Trial Pilot Study

47. Use of intravenous immunoglobulins in clinical practice: data from three French university hospitals

50. Reduced Cancer Incidence in Huntington's Disease: Analysis in the Registry Study

Catalog

Books, media, physical & digital resources